Augmentation with ketone bodies improves cognitive function in Advertisement patients Accera, Inc., a biotechnology company delivering breakthrough treatments in central nervous program illnesses, announced data which demonstrated that augmentation with ketone bodies considerably improved cognitive function in Alzheimer’s disease sufferers cabergoline05mg.com read more . One strategy has gone to dietary supplement the brain’s regular glucose source with ketone bodies. At Day time 45 the improvement in ADAS-cog score in accordance with Placebo was 6. Samuel Henderson, Vice President of Analysis, will present these results at the 25th International Meeting of Alzheimer’s Disease International.